Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain. [electronic resource]
Producer: 20070205Description: 447-57 p. digitalISSN:- 1173-2563
- Adult
- Antipsychotic Agents -- administration & dosage
- Chronic Disease
- Cost-Benefit Analysis -- methods
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Humans
- Models, Econometric
- Piperazines -- administration & dosage
- Program Evaluation -- methods
- Recurrence
- Reproducibility of Results
- Schizophrenia -- economics
- Spain
- Thiazoles -- administration & dosage
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.